RecruitingNCT06481943

A Prospective Research Investigation of Ischemia Using MCG

A Prospective Research Investigation of Ischemia Using SandboxAQ Magnetocardiography Device

Sponsor

SB Technology, Inc.

Enrollment

335 participants

Start Date

Jul 11, 2024

Study Type

OBSERVATIONAL

Conditions

Acute Coronary Syndrome

Summary

PRISM is a prospective, pilot research study that aims to systematically characterize the usefulness of CardiAQ MCG, a bedside magnetocardiography device, in the evaluation of myocardial ischemia and infarction status.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Sponsor MCG device (CardiAQ) for people with acute coronary syndrome. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.